TORONTO, ONTARIO — (Marketwired) — 03/03/17 — Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
Effective Date: March 3, 2017
Symbol: ATT
Contacts:
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340